Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.230
+0.050 (4.24%)
Jun 27, 2025, 4:00 PM - Market closed
Cytosorbents Employees
Cytosorbents had 149 employees as of December 31, 2024. The number of employees decreased by 37 or -19.89% compared to the previous year.
Employees
149
Change (1Y)
-37
Growth (1Y)
-19.89%
Revenue / Employee
$237,129
Profits / Employee
-$108,111
Market Cap
77.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CTSO News
- 4 days ago - CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR - PRNewsWire
- 4 weeks ago - CytoSorbents to Participate at the Jefferies Global Healthcare Conference - PRNewsWire
- 5 weeks ago - CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025 - PRNewsWire
- 6 weeks ago - Cytosorbents Corporation (CTSO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - CytoSorbents Provides Regulatory Update for DrugSorb-ATR - PRNewsWire
- 2 months ago - CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 2 months ago - CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program - PRNewsWire